IMM

Immupharma (IMM)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:IMM
DataOraFonteTitoloSimboloCompagnia
03/05/202408:00RNS Regulatory NewsImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
24/04/202408:12RNS Non-RegulatoryImmupharma PLC IMMUPHARMA AT BIO-EQUITY 2024 12-14 MayLSE:IMMImmupharma Plc
19/04/202408:00RNS Regulatory NewsImmupharma PLC Grant of Share OptionsLSE:IMMImmupharma Plc
02/04/202413:52Alliance NewsAlliance NewsImmupharma jumps amid new IP strategy for P140 technology platformLSE:IMMImmupharma Plc
02/04/202408:03RNS Regulatory NewsImmupharma PLC New intellectual property strategy initiatedLSE:IMMImmupharma Plc
25/03/202413:20Alliance NewsAlliance NewsIncanthera says first order from skincare deal doublesLSE:IMMImmupharma Plc
25/03/202408:25RNS Regulatory NewsImmupharma PLC Incanthera provides Comm'l Update/Revenue F'castsLSE:IMMImmupharma Plc
14/03/202408:00RNS Non-RegulatoryImmupharma PLC IMMUPHARMA AT BIO-EUROPE SPRING 2024LSE:IMMImmupharma Plc
06/03/202414:05Alliance NewsAlliance NewsEARNINGS AND TRADING: Challenger signs farm-out; Ricardo revenue upLSE:IMMImmupharma Plc
06/03/202408:00RNS Regulatory NewsImmupharma PLC Financial, Business and Portfolio Develop't UpdateLSE:IMMImmupharma Plc
19/12/202318:52Alliance NewsAlliance NewsEARNINGS AND TRADING: Time Finance revenue up; Libertine loss narrowsLSE:IMMImmupharma Plc
19/12/202308:00UK RegulatoryImmupharma PLC Simbec-Orion appointed as CROLSE:IMMImmupharma Plc
18/12/202308:15UK RegulatoryImmupharma PLC Incanthera - Comm'l Skincare Deal/GBP1M FundraiseLSE:IMMImmupharma Plc
07/09/202318:07Alliance NewsAlliance NewsTRADING UPDATES: RA International loss narrows as revenue growsLSE:IMMImmupharma Plc
07/09/202308:00UK RegulatoryImmupharma PLC Result of Retail Offer and Director ShareholdingLSE:IMMImmupharma Plc
31/08/202314:05Alliance NewsAlliance NewsImmuPharma launches GBP2 million fund raise as interim loss narrowsLSE:IMMImmupharma Plc
31/08/202308:02UK RegulatoryImmupharma PLC WRAP Retail Offer for up to GBP0.5mLSE:IMMImmupharma Plc
31/08/202308:01UK RegulatoryImmupharma PLC Subscription to raise GBP1.35m; Sharing Agr, RPTLSE:IMMImmupharma Plc
31/08/202308:00UK RegulatoryImmupharma PLC Interim resultsLSE:IMMImmupharma Plc
21/08/202308:00UK RegulatoryImmupharma PLC Extension of warrants in Incanthera plcLSE:IMMImmupharma Plc
11/08/202313:04UK RegulatoryImmupharma PLC Directorate ChangeLSE:IMMImmupharma Plc
30/06/202314:12UK RegulatoryImmupharma PLC Result of AGMLSE:IMMImmupharma Plc
19/06/202313:02Alliance NewsAlliance NewsIN BRIEF: ImmuPharma to start next two phases of Lupuzor trialLSE:IMMImmupharma Plc
19/06/202308:00UK RegulatoryImmupharma PLC Lupuzor UpdateLSE:IMMImmupharma Plc
06/06/202308:00UK RegulatoryImmupharma PLC IMM RNS Posting of RA and Notice of AGM 30 June 23LSE:IMMImmupharma Plc
18/05/202313:12Alliance NewsAlliance NewsIN BRIEF: ImmuPharma rises on FDA feedback for neurological diseaseLSE:IMMImmupharma Plc
18/05/202311:38Dow Jones NewsImmuPharma Shares Rise on Positive Guidance From US FDA for P140LSE:IMMImmupharma Plc
18/05/202308:00UK RegulatoryImmupharma PLC Positive Pre-IND meeting with FDALSE:IMMImmupharma Plc
11/05/202312:48Alliance NewsAlliance NewsIN BRIEF: ImmuPharma annual loss narrows as R&D spending reducedLSE:IMMImmupharma Plc
11/05/202308:00UK RegulatoryImmupharma PLC Final ResultsLSE:IMMImmupharma Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:IMM
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network